-
Mashup Score: 6
DENVER — Phase 2 study data showed that a once-weekly oral regimen of an investigational two-drug HIV treatment was well tolerated among patients with HIV and allowed them to maintain viral suppression.
Source: www.healio.comCategories: General Medicine News, Infectious DiseaseTweet
💊Phase 2 study data presented at #CROI2024 showed that a once-weekly oral regimen of an investigational two-drug #HIV treatment was well tolerated among patients with HIV and allowed them to maintain #ViralSuppression. #IDtwitter Click 👇 for more https://t.co/idtH55cSWe